Our observation suggest that the aberrant TGF-β1 expression in cholangiocarcinoma may led to reduced miR-29a level, which in turn affects the histone acetylation level and thereby facilitates carcinogenesis and tumor progression. This evidence concerns the gene TGFB1 and cholangiocarcinoma.